NICHOLE SHARP: Open Payments
NPI 1952751034 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 45 payments from 6 companies in 2025. Trend: 2023 $585 · 2024 $481 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $245 |
| Lilly USA, LLC | 18 | $229 |
| Xeris Pharmaceuticals, Inc. | 8 | $147 |
| ABBVIE INC. | 3 | $54 |
| Corcept Therapeutics | 2 | $41 |
| Soleno Therapeutics, Inc. | 1 | $23 |
Products named: MOUNJARO, RECORLEV, Ozempic, Wegovy, Korlym, UBRELVY, VYKAT XR, QULIPTA.
Industry payments across WA — which companies pay providers there.
